Posted in | News | Imaging | Medical Optics

Asia-Pacific and Europe Region Present Best Growth Opportunities for Smart Pills Technologies Market

Research and Markets has announced the addition of the "Smart Pills Technologies Market (2012-2017) (Diagnostic imaging, patient monitoring, drug delivery)" report to their offering.

Gastro-Intestinal (GI) disorders are becoming more prevalent in our day to day life owing changing lifestyles, dietary habits and aging population. The effective therapeutics and sources or unknown causes of bleeding for some of the GI disorders are still an enigma to the medical industry due to lack of effective medical devices that reach the contours of small intestine. Although there are flexible endoscopes, they still cause discomfort to the patients due to insertion of wired tube into the body. The advancements in the field of medical science and technology and the emergence of micro and nanotechnology have paved the way for miniaturized wireless capsule endoscopes, also called as capsule endoscopes. These micro capsules can also be used for site-specific drug delivery and effective patient monitoring. This novel approach, enabled by Bio-MEMS is called as Smart Pills. This technology is not only comfortable for patients, but also enables the healthcare providers to take on-time remedical action effectively.

The best growth opportunities for Smart Pills are in the Asia-Pacific and Europe region, whereas mature North American and West European markets are predictable to register a modest growth. In mature markets such as the U.S., Western Europe, growth will be driven more by a shift towards non- invasive devices by physicians and patients. Presence of high density population and growing healthcare awareness drives the smart pills market in Asia-Pacific and Middle-East region.

Thorough investment analysis and multi-criteria based AHP analysis on smart pill technology in the report enables the potential growth and adoption of smart pills in near future.

We have used various secondary sources such as encyclopedia, directories, and databases to identify and collect information useful for this extensive commercial study of biocide market. The primary sources - experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess the future prospects of Smart Pills.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Smart Pills- Technology Snapshot

4 Technology Trend Analysis

5 Market Landscape Analysis

6 Investor Analysis And Investment Opportunities

7 Smart Pills-Geographic Analysis

8 Competitive Landscape

9 Analyst Insights And Recommendations

10 Key Profiles - Companies And Universities

11 Appendix

Companies Mentioned

  • Acamp (Canada)
  • Bio-Images Research Limited
  • Boston Scientific Corp
  • Capsovision, Inc.
  • Cerner Healthcare Private Limited
  • Fujifilm Holding Corporation
  • Ge Healthcare
  • Given Imaging Limited
  • Ibm Endicott
  • Karl Storz
  • Lloyd Pharmacy Limited
  • Mckesson Corporation
  • Medimetrics, Inc.
  • Medtronic, Inc
  • Novartis Pharma
  • Olympus Medical Technology
  • Pentax Medical Company
  • Philips Applied Technologies
  • Proteus Digital Health
  • Siemens Healthcare
  • Smart Pill, Inc.
  • Smith & Nehpew
  • Stryker Corporation
  • University Spin Off Hot Spots

For more information visit http://www.researchandmarkets.com/research/8fwr7p/smart_pills

Source: http://www.researchandmarkets.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.